Raymond James expands Biotechnology Research Team
ST. PETERSBURG, FL. – Raymond James has hired Dane Leone as managing director responsible for biotechnology coverage in the firm’s Equity Research department. He joins the firm’s existing equity research analysts focused on the biotechnology sector: Reni Benjamin, Laura Chico and Steve Seedhouse, as well as Elliot Wilbur, who covers specialty pharmaceuticals.
“I am delighted to welcome Dane to join our biotech team,” said Brian Alexander, Director of Equity Research. “His reputation for analytical rigor, comprehensive research and objective investment advice makes him an ideal candidate to grow our life sciences franchise. With Dane’s addition, we look forward to meaningful coverage expansion of middle-market growth companies in key therapeutic areas.
“In an environment where many of our competitors are questioning their commitment to research, Raymond James remains dedicated to producing unique, thought-provoking and differentiated insights for our clients. We strongly believe that our breadth and depth of coverage, with a keen focus on small and mid-cap stocks, differentiates us from our competitors,” he added.
Leone joins Raymond James from BTIG, where he spent four years covering biotechnology stocks, having previously covered medical technology. Prior to working at BTIG, he spent over four years as a healthcare services analyst at Macquarie. Before moving to the sell-side in 2010, Leone spent five years on the buy-side at Alliance Bernstein, where he not only covered the healthcare sector, but also doubled as a quantitative strategist.
Leone graduated from the State University of New York at Albany with a major in financial analysis and a minor in economics.
“I am excited to join the Raymond James life sciences team,” said Leone, “and contribute to the continued growth of a highly distinguished equity research platform.”
Leone is based in the Raymond James Park Avenue office in New York City.
About Raymond James Financial, Inc.
Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 7,700 financial advisors in over 3,000 locations throughout the United States, Canada and overseas. Total client assets are approximately $788 billion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at www.raymondjames.com. Raymond James & Associates, Inc., member New York Stock Exchange/SIPC.